Atlas Trials

Metastatic NSCLC

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic NSCLC

RecordFirmDate
SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation (NCT05480865)Navire Pharma Inc., a BridgeBio company2022-07-06
Patient's Whole Process Follow-up Management(HOPE-1) (NCT05339568)Qianfoshan Hospital2022-05-22
De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction (NCT05255302)Intergroupe Francophone de Cancerologie Thoracique2022-05-02
Use of Chinese Herbal Formula Shu Yu Wan in Lung Cancer Patients (NCT04615884)Lady Davis Institute2022-03-01
Immunotherapy Clearance and Phenotype of Circulating Tumor Cells in Lung and Head and Neck Cancers (NCT05091190)Hospices Civils de Lyon2021-10-27
Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC (NCT04846452)The First Affiliated Hospital with Nanjing Medical University2021-06-01
Tumoral Bone Strength Assessment by Numerical Simulation Using Quantitative CT : the MEKANOS Study (NCT04170634)Hospices Civils de Lyon2019-11-28
NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy (NCT03589339)Nanobiotix2019-01-16
GRN-1201 With Pembrolizumab in Subjects With Metastatic PD-L1+ NSCLC (NCT03417882)BrightPath Biotherapeutics2019-01-03
Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer (NCT01438307)University of Alabama at Birmingham2011-09-01

Track Metastatic NSCLC automatically

Every clearance here is in the API, with alerts when new ones post.